Anna Birnhuber

Dr. Anna Birnhuber

orcid

Biography

2019: PhD in "Molecular Medicine" at the Medical University of Graz 2019-2021: PostDoc at the Ludwig Boltzmann Institute for Lung Vascular Research 2021-2024: Division of Physiology and Pathophysiology, Otto Loewi Research Center, MedUniGraz 2024-now: Otto Loewi Research Center, Lung Research Cluster, MedUniGraz Research Interest: pathomechanisms of pulmonary circulation and chronic lung diseases; molecular mechanisms of disturbed endothelial-immune cell crosstalk in the development chronic lung diseases. Publication highlights: - Birnhuber et al., Eur Respir J 2019: showed how IL-1 can dampen collagen production of pulmonary mesenchymal cells and balances pro-fibrotic actions of the immune system. - Birnhuber et al., Resp Research 2020: indicated an increase of pulmonary fibrosis and inflammation in the bleomycin-induced lung fibrosis model following administration of CDK4/6 inhibitor Palbociclib - Birnhuber et al., Eur Respir J 2022: highlighted how pirfenidone worsens pulmonary function in the Fra-2 TG SSc-ILD model due to its negative effects on endothelial cells primed by type 2 inflammation. - Birnhuber et al., Am J Physiol Lung Cell Mol Physiol 2025: demonstrated that pulmonary hypertension in the Fra-2 TG mouse model is multifactorial, conjointly elicited by type inflammation, increased vasoconstriction and progressive pulmonary arterial remodeling

Affiliations

No affiliation has been shared yet.

Honors and Awards

honor

ALFA Prize 2022

Austrian Society of Pneumonology and Austrian Lung Fibrosis Associated

For the study „Pirfenidone exacerbates Th2-driven vasculopathy in a mouse model of SSc-ILD” published in the European Respiratory Journal, Oct 20;60(4)

honor

Rene-Baumgart Prize 2020

Forschungspreis der René-Baumgart-Stiftung 2020

For the study “IL-1 receptor blockade skews inflammation towards Th2 in a mouse model of systemic sclerosis” published in the European Respiratory Journal, 2019 Sep 29;54(3).

honor

Poster Award 1st Prize

Austrian Society of Pneumology

Targeting innate immunity exacerbates inflammation and pulmonary fibrosis in a systemic sclerosis-associated lung disease model; Austrian Society of Pneumology Annual Meeting 2019, OCT 10-12, 2019; Vienna, Austria

honor

European Respiratory Society Travel Grant 2018

ÖGP (Austrian Society of Pneumology)

honor

American Thoracic Society Travel Grant 2017

ÖGP (Austrian Society of Pneumology)

honor

ÖGP-Short term fellowship 2015

ÖGP (Austrian Society of Pneumology)

“Hypoxic pulmonary vasoconstriction in pulmonary fibrosis using the isolated and perfused mouse lung model”

honor

European Respiratory Society Short-Term Research Training Fellowship 2015

European Respiratory Society

“The role of infections in acute respiratory worsening in lung fibrosis”

Experience

No experience has been shared yet.